Dannemiller

GLP-1 and the CNS Regulation of Appetite

Overview / Abstract:	Intended Audience Physicians, Nurse Practitioners, Registered Dietitians, Registered Nurses. Learning Objectives Upon completion of this activity, the participant should be able to: Review peripheral biological mechanisms through which GLP-1 and GLP-1 analogs reduce food intake Identify brain regions through which GLP-1 and GLP-1 analogs act to reduce food intake Understand the role of nausea in the food intake reductions with GLP-1 analog treatment
Expiration	Dec 31, 2020
Discipline(s)	Dietetics / Dietitian CE, Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME
Format	Webinar / Webcast / Video
Credits / Hours	1
Accreditation	ACCME (AMA), ANCC, AANP, AANA, NCCPA, CDR
Presenters / Authors / Faculty	Scott Kanoski, PhD
Activity Specialities / Related Topics	Anatomy / Physiology, Diabetes, Family Medicine, Obesity / Weight Management, Pediatrics, Primary Care
Sponsors / Supporters / Grant Providers	Supported by an educational grant from Novo Nordisk Inc.
Keywords / Search Terms	Dannemiller Dannemiller Dannemiller Dannemiller Dannemiller Dannemiller Dannemiller, obesity, bariatric, diabetes, Lecture Recordings, Videos, robard, obese, overweight, free cme Free CE CME Free CE CME Free CE CME Free CE CME Free CE CME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map